Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (151-160 of 215) with videos related to

Pageof 22
Sort By:
Leukemia|February 13, 2002
Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantationN Schaap, A Schattenberg, E Mensink, et al.
Bone Marrow Transplantation|December 18, 2012
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burdenN Blijlevens, M de Château, G Krivan, et al.
Blood|September 6, 2001
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenaseF A Wagener, A Eggert, O C Boerman, et al.
British Journal of Haematology|February 5, 1998
Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphomaC M Mandigers, J M Raemaekers, A V Schattenberg, et al.
Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.
JAMA|July 7, 1993
Outcome after allogeneic bone marrow transplant for leukemia in older adultsO Ringdén, M M Horowitz, R P Gale, et al.
International Journal of Pharmaceutics|June 9, 2001
Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot studyY V van Oosterhout, J L van Emst, H H Bakker, et al.
Radiology|November 27, 2014
Sigmoid cancer versus chronic diverticular disease: differentiating features at CT colonographyLeonie M J Lips, Pierre T J Cremers, Perry J Pickhardt, et al.
Leukemia|September 10, 2005
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative GroupH Zwierzina, S Suciu, J Loeffler-Ragg, et al.
Blood|June 1, 1984
T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft-versus-host diseaseJ W Gratama, A Naipal, P Oljans, et al.
Pageof 22

Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
Leukemia|February 13, 2002
Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantationN Schaap, A Schattenberg, E Mensink, et al.
Bone Marrow Transplantation|December 18, 2012
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burdenN Blijlevens, M de Château, G Krivan, et al.
Blood|September 6, 2001
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenaseF A Wagener, A Eggert, O C Boerman, et al.
British Journal of Haematology|February 5, 1998
Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphomaC M Mandigers, J M Raemaekers, A V Schattenberg, et al.
Blood|November 14, 1997
Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow TransplantationT De Witte, A Van Biezen, J Hermans, et al.
JAMA|July 7, 1993
Outcome after allogeneic bone marrow transplant for leukemia in older adultsO Ringdén, M M Horowitz, R P Gale, et al.
International Journal of Pharmaceutics|June 9, 2001
Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot studyY V van Oosterhout, J L van Emst, H H Bakker, et al.
Radiology|November 27, 2014
Sigmoid cancer versus chronic diverticular disease: differentiating features at CT colonographyLeonie M J Lips, Pierre T J Cremers, Perry J Pickhardt, et al.
Leukemia|September 10, 2005
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative GroupH Zwierzina, S Suciu, J Loeffler-Ragg, et al.
Blood|June 1, 1984
T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft-versus-host diseaseJ W Gratama, A Naipal, P Oljans, et al.
Pageof 22